SEC Form 4 · accession 0001144204-15-070202
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Charles Drexler
Director · 10% Owner
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 9:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secured Convertible NoteF1,F2,F4,F3 | $2.30 | Dec 7, 2015 | J | — | A | — | Jan 15, 2017 | Common Stock | 2,608,696 | 2,608,696 | D |
Explanation of responses
- F1MusclePharm Corporation issued a $6,000,000 secured convertible note to Mr. Drexler. The interest rate is 8% and the note will mature on January 15, 2017.
- F2As of the Transaction Date, Mr. Drexler has not acquired any derivative securities.
- F3Exerciseable immediately at the election of the reporting person.
- F4As of the date hereof, Mr. Drexler has an indirect ownership interest of 1,431,924 common stock shares via Consac, LLC.